Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15).
TNM staging
disease-free survival
machine learning
partial nephrectomy
renal cell carcinoma
Journal
BJU international
ISSN: 1464-410X
Titre abrégé: BJU Int
Pays: England
ID NLM: 100886721
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
medline:
24
7
2023
pubmed:
18
1
2023
entrez:
17
1
2023
Statut:
ppublish
Résumé
To assess the impact of pathological upstaging from clinically localized to locally advanced pT3a on survival in patients with renal cell carcinoma (RCC), as well as the oncological safety of various surgical approaches in this setting, and to develop a machine-learning-based, contemporary, clinically relevant model for individual preoperative prediction of pT3a upstaging. Clinical data from patients treated with either partial nephrectomy (PN) or radical nephrectomy (RN) for cT1/cT2a RCC from 2000 to 2019, included in the French multi-institutional kidney cancer database UroCCR, were retrospectively analysed. Seven machine-learning algorithms were applied to the cohort after a training/testing split to develop a predictive model for upstaging to pT3a. Survival curves for disease-free survival (DFS) and overall survival (OS) rates were compared between PN and RN after G-computation for pT3a tumours. A total of 4395 patients were included, among whom 667 patients (15%, 337 PN and 330 RN) had a pT3a-upstaged RCC. The UroCCR-15 predictive model presented an area under the receiver-operating characteristic curve of 0.77. Survival analysis after adjustment for confounders showed no difference in DFS or OS for PN vs RN in pT3a tumours (DFS: hazard ratio [HR] 1.08, P = 0.7; OS: HR 1.03, P > 0.9). Our study shows that machine-learning technology can play a useful role in the evaluation and prognosis of upstaged RCC. In the context of incidental upstaging, PN does not compromise oncological outcomes, even for large tumour sizes.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
160-169Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2023 The Authors. BJU International published by John Wiley & Sons Ltd on behalf of BJU International.
Références
Hamilton ZA, Capitanio U, Pruthi D et al. Risk factors for upstaging, recurrence, and mortality in clinical T1-2 renal cell carcinoma patients upstaged to pT3a disease: an international analysis utilizing the 8th edition of the tumor-node-metastasis staging criteria. Urology 2020; 138: 60-8
Renard AS, Nedelcu C, Paisant A et al. Is multidetector CT-scan able to detect T3a renal tumor before surgery? Scand J Urol 2019; 53: 350-5
Landman J, Park JY, Zhao C et al. Preoperative computed tomography assessment for perinephric fat invasion: comparison with pathological staging. J Comput Assist Tomogr 2017; 41: 702-7
Ljungberg B, Albiges L, Abu-Ghanem Y et al. European association of urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol 2019; 75: 799-810
Ghanie A, Formica MK, Wang D, Bratslavsky G, Stewart T. Pathological upstaging of clinical T1 renal cell carcinoma: an analysis of 115,835 patients from National Cancer Data Base, 2004-2013. Int Urol Nephrol 2018; 50: 237-45
Veccia A, Falagario U, Martini A et al. Upstaging to pT3a in patients undergoing partial or radical nephrectomy for cT1 renal tumors: a systematic review and meta-analysis of outcomes and predictive factors. Eur Urol Focus 2021; 7: 574-81
Obermeyer Z, Emanuel EJ. Predicting the future - big data, machine learning, and clinical medicine. N Engl J Med 2016; 375: 1216-9
Jayatilake SMDAC, Ganegoda GU. Involvement of machine learning tools in healthcare decision making. J Healthc Eng 2021; 2021: e6679512
de la Barra CC, González PG, Baeza MÁ, Pérez OP, Cruzat JD. A preoperative model to predict pT3 upstaging in clinically localized renal cell carcinoma. Cent Eur J Urol 2020; 73: 173-7
Nocera L, Stolzenbach LF, Ruvolo CC et al. Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 2021; 47: 1187-90
Liu H, Wang Z, Peng E, Chen Z, Tang K, Xia D. Added value of systemic inflammation markers in predicting clinical stage T1 renal cell carcinoma pathologically upstaged to T3a. Front Oncol 2021; 11: 679536
Edge SB, Compton CC. The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-4
Chatton A, Le Borgne F, Leyrat C et al. G-computation, propensity score-based methods, and targeted maximum likelihood estimator for causal inference with different covariates sets: a comparative simulation study. Sci Rep 2020; 10: 9219
Uddin S, Khan A, Hossain ME, Moni MA. Comparing different supervised machine learning algorithms for disease prediction. BMC Med Inform Decis Mak 2019; 19: 281
Saito T, Rehmsmeier M. The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets. PLoS One 2015; 10: e0118432
Lundberg SM, Lee SI. A unified approach to interpreting model predictions. In Curran Associates Inc. ed, Proceedings of the 31st International Conference on Neural Information Processing Systems. Red Hook, NY: Curran Associates Inc., 2017: 4768-77
Ravaud A, Motzer RJ, Pandha HS et al. Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy. N Engl J Med 2016; 375: 2246-54
Choueiri TK, Tomczak P, Park SH et al. Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma. N Engl J Med 2021; 385: 683-94
Pal SK, Uzzo R, Karam JA et al. Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial. Lancet Lond Engl 2022; 400: 1103-16
Patel SH, Uzzo RG, Larcher A et al. Oncologic and functional outcomes of radical and partial nephrectomy in pT3a pathologically upstaged renal cell carcinoma: a multi-institutional analysis. Clin Genitourin Cancer 2020; 18: e723-9
Chung DY, Kang DH, Kim JW, Kim DK, Lee JY, Cho KS. Comparison of oncologic outcomes between partial nephrectomy and radical nephrectomy in patients who were upstaged from cT1 renal tumor to pT3a renal cell carcinoma: an updated systematic review and meta-analysis. Ther Adv Urol 2020; 12: 1756287220981508
Wood EL, Adibi M, Qiao W et al. Local tumor bed recurrence following partial nephrectomy in patients with small renal masses. J Urol 2018; 199: 393-400
Kim H, Lee SJ, Park SJ, Choi IY, Hong SH. Machine learning approach to predict the probability of recurrence of renal cell carcinoma after surgery: prediction model development study. JMIR Med Inform 2021; 9: e25635
Patard JJ, Kim HL, Lam JS et al. Use of the University of California los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol 2004; 22: 3316-22
Leibovich BC, Blute ML, Cheville JC et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 2003; 97: 1663-71
Beisland C, Hjelle KM, Reisaeter LAR, Bostad L. Observation should be considered as an alternative in management of renal masses in older and comorbid patients. Eur Urol 2009; 55: 1419-27
Spaliviero M, Poon BY, Aras O et al. Interobserver variability of R.E.N.a.L., PADUA, and centrality index nephrometry score systems. World J Urol 2015; 33: 853-8
Troyanskaya O, Cantor M, Sherlock G et al. Missing value estimation methods for DNA microarrays. Bioinformatics 2001; 17: 520-5
Bernhard JC, Pantuck AJ, Wallerand H et al. Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma. Eur Urol 2010; 57: 1080-6
Long W, Chen J, Gao C, Lin Z, Xie X, Dai H. Brief review on the roles of neutrophils in cancer development. J Leukoc Biol 2021; 109: 407-13